Features and risk factors of post-COVID-19 syndrome: findings from a longitudinal study in Bangladesh

Afroze, Farzana; Arafat, Shohael Mahmud; Ahmed, C M; Alam, Baharul; Islam, Md Zahidul; Mahfuz, Mustafa; Parvin, Irin; Ackhter, Mst. Mahmuda; Shormi, Israt; Islam, Farhana; Sultana, Monjeline; Chowdhury, Aina Niran; Rahaman, Mohammad Ferdous Ur; Khan, Anisur Rahman; Hasan, Md Nazmul; Ahmed, Shahriar; Chisti, Mohammod Jobayer; Ahmed, Tahmeed

doi:10.1016/j.lansea.2022.100134

Cited by 10 publications

(7 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Embora a COVID-19 longa possa acometer tantos pacientes hospitalizados (22,26,27,29,35) , quanto os não hospitalizados (13,14) e têm sido considerados fatores associados a essa síndrome. Um estudo realizado em Bangladesh, acompanhou os recuperados da COVID-19 nos meses 1, 3 e 5 após a alta e verificou-se que a idade avançada, ser do sexo feminino, comorbidades, tabagismo e hospitalização foram independentemente associados à síndrome pós-COVID-19 (19) .…”

Section: Discussionunclassified

See 1 more Smart Citation

SÍNDROME PÓS-COVID-19: uma revisão integrativa

Da Silva Brilhnante,

De Almeida Corrêa,

De Mattos

et al. 2024

Rev. Enferm. Atual In Derme

View full text Add to dashboard Cite

Introdução: A síndrome pós-COVID-19 é definida como um conjunto de sintomas persistentes da doença aguda causada pelo vírus SARS-Cov-2 não atribuídas a outras causas. Essa condição clínica acomete uma parcela significativa da população com impacto na sua qualidade de vida e nos cuidados de saúde. Objetivo: Identificar na literatura sobre a síndrome pós-COVID-19, e descrever a sua prevalência e principais manifestações clínicas. Método: Trata-se de uma revisão integrativa com inclusão de artigos de acesso via Pubmed, Lilacs e Scielo publicados entre janeiro de 2022 a julho de 2023, com os descritores sendo post-COVID-19/pós-COVID-19; long-COVID-19/COVID-19 longa, post-acute sequelae of COVID-19/sequelas pós-COVID-19 aguda, prevalence/prevalência, clinical manifestations/manifestações clínicas. Identificou-se 525 artigos dos quais 26 foram analisados e compuseram a amostra Resultados: A prevalência de síndrome pós-COVID-19 descrita na literatura variou de 10% a 93% e os estudos avaliaram os pacientes em períodos que compreenderem 1 mês até 12 meses após a infecção aguda. As manifestações clínicas no pós-COVID-19 podem envolver múltiplos órgão e afetar qualquer um dos sistemas orgânicos. Fadiga, dispneia e anosmia foram as alterações clínicas mais citadas na literatura. Conclusão: A prevalência de síndrome pós-COVID-19 é variável de acordo com a população em estudo, todavia, atinge uma parcela significativa dos infectados pelo vírus SARS-Cov-2. Diante da variedade de sintomas clínicos persistentes é essencial que o cuidado aos pacientes seja realizado por uma equipe multiprofissional em saúde. Os serviços de saúde devem estar capacitados para atuar diante desse problema de saúde mundial que se perpetua para o período pós-pandêmico.

show abstract

Section: Discussionunclassified

“…Outros fatores associados à síndrome pós-COVID-19 são obesidade, perfil socioeconômico, hospitalização e posição de prona (13,14,15,19,26,27) .…”

Section: Discussionunclassified

SÍNDROME PÓS-COVID-19: uma revisão integrativa

Da Silva Brilhnante,

De Almeida Corrêa,

De Mattos

et al. 2024

Rev. Enferm. Atual In Derme

View full text Add to dashboard Cite

show abstract

“…Data on long COVID-19 are scare in sub-Saharan Africa, especially in Central Africa. According to the litterature, the probability of having long COVID is known to be higher in patients than in outpatients [15]. These patients are also more likely to participate in post-illness follow-up consultations.…”

Section: Discussionmentioning

confidence: 99%

“…Neurocognitive or neuropsychological symptoms such as headaches, anosmia, difficulty concentrating, sleep disorders are also described during long COVID [15,17,26]. Anosmia and ageusia, already infrequent in the cohort during hospitalization, were no longer found in the 3rd month.…”

Section: Long Covid Type Of Symptoms and Evolutionmentioning

confidence: 99%

Post-COVID-19 Clinical Symptom Frequency and Associated Factors in a Cohort of Patients Discharged from the ICU and Monitored for 12 Months, in Libreville, Gabon

Charleine,

Bridy,

Moukady

et al. 2023

IJTDH

View full text Add to dashboard Cite

Aims: This study determined the prevalence and evolution of long COVID symptoms in patients hospitalized for severe COVID-19 at the CHUL intensive care unit in Libreville, Gabon. Study Design: Prospective, longitudinal, study. Place and Duration of Study: Infectiology Unit, Centre Hospitalier Universitaire de Libreville Hospitalier Universitaire de LibrevH (CHUL), between January 2021 and January 2022. Methodology: We included 144 patients (84 men, 60 women; median age 46.4 [16-88] years) hospitalized in the intense care unit for a RT-PCR- confirmed COVID-19 and who have accepted a one-year follow-up. All patients were consulted quarterly for 12 months. During the follow-up, existence, appearance and types of symptoms were sought at 3, 6 and 12-months post-hospitalization. Results: The prevalence of long COVID-19 was 52.1% (n=75/144). Fatigue (21.3%), cough (20.8%), sleep disorders (16.0%) and anxiety (11.1%) predominated at month-3. The main symptoms reported 6-months after the onset of infection were dyspnea (9.7%; n=14), anxiety (7.6%; n=11), fatigue (6.2%; n=9) and cough (3.5%; n=5). One year after, the persistent symptoms were anxiety (6.5%; n=9), dyspnea (1.4%; n=2). Most participants had only one symptom: 60% at month-3, 79.5% at month-6 and 77.8% at 12-months (p=0.04). Conclusion: The long COVID is frequent among patients hospitalized for severe form of SARS-COV-2 infection. It is imperative to continue generating information for appropriate prevention and monitoring measures to be adopted in Gabon.

show abstract

“…If the participants did not indicate symptoms, they were considered without Long COVID (No); but if the participants checked one or more symptoms, they were considered to have Long COVID (Yes) ( 14 , 15 ).…”

Section: Methodsmentioning

confidence: 99%

Risk and protective factors for Long COVID in Brazilian adults (CUME Study)

Eduvirgem,

Bressan,

Hermsdorff

et al. 2024

Front. Med.

View full text Add to dashboard Cite

BackgroundMost people recover from COVID-19, however, between 5 to 20% have experienced new, recurring, or continuous health problems four or more weeks after being infected, a phenomenon called Long COVID, and whose reasons for its manifestation are incipient. Our objective was to analyse the risk and protective factors for Long COVID in Brazilian adults participating in the CUME Study.MethodsThe CUME Study is a prospective cohort conducted with graduates from federal universities in the State of Minas Gerais, Brazil. In this study, 390 participants who answered the baseline questionnaire in 2016 and the third follow-up questionnaire in 2022 (which contained a block of questions about occurrence of COVID-19 and Long COVID) were included. The diagnosis of Long COVID was based on self-reporting of persistence of signs and symptoms of COVID-19 between 30 days and 6 months after remission of the disease. To estimate the risk and protective factors for Long COVID, a hierarchical multivariate statistical analysis was conducted using the Poisson regression technique.ResultsLong COVID was observed in 48.9% of the participants. The following characteristics were identified as risk factors for the outcome: female sex (RR = 1.56; 95% CI = 1.22–1.99); prior diagnosis of hypertension (RR = 1.46; 95% CI = 1.19–1.80); having contracted COVID-19 in the first (RR =1.38; 95% CI = 1.07–1.79) or in the second waves (RR = 1.33; 95% CI = 1.07–1.65) of the pandemic period; and having presented three or more signs and symptoms during the acute phase of COVID-19 (RR = 2.99; 95% CI = 1.08–8.24). On the other hand, having a doctoral/postdoctoral educational level (RR = 0.69; 95% CI = 0.50–0.94) was identified as a protective factor for the outcome.ConclusionHealth system managers and healthcare professionals should be aware of the socioeconomic profile and disease history of patients who have had COVID-19 because women, people with a prior diagnosis of hypertension, and those who manifested multiple signs and symptoms of COVID-19 during the acute phase of the disease were at greater risk of developing Long COVID.

show abstract

Features and risk factors of post-COVID-19 syndrome: findings from a longitudinal study in Bangladesh

Cited by 10 publications

References 27 publications

SÍNDROME PÓS-COVID-19: uma revisão integrativa

SÍNDROME PÓS-COVID-19: uma revisão integrativa

Post-COVID-19 Clinical Symptom Frequency and Associated Factors in a Cohort of Patients Discharged from the ICU and Monitored for 12 Months, in Libreville, Gabon

Risk and protective factors for Long COVID in Brazilian adults (CUME Study)

Contact Info

Product

Resources

About